PHARMACOLOGICAL PROPERTIES AND TERATOGENIC ACTION OF 2-(HEXAHYDROPHTHALIMIDO) GLUTARIMIDE AND 2-PHTHALIMIDO-N-METHYLGLUTARIMIDE.
D000014:Abnormalities, Drug-Induced; D000818:Animals; D005260:Female; D006801:Humans; D051379:Mice; D010880:Piperidines; D010881:Piperidones; D011247:Pregnancy; D011270:Pregnancy, Animal; D011817:Rabbits; D012106:Research; D013792:Thalidomide; D014116:Toxicology
D010880:Piperidines; D010881:Piperidones; D013792:Thalidomide; C007864:glutarimide
ABNORMALITIES, DRUG-INDUCED; EXPERIMENTAL LAB STUDY; MICE; PIPERIDINES; PREGNANCY; PREGNANCY, ANIMAL; RABBITS; THALIDOMIDE; TOXICOLOGIC REPORT